Corticotropin-releasing factor inhibits the acute inflammatory response of rat pawskin to cold injury.
The anti-inflammatory effects of human/rat corticotropin-releasing factor (CRF), a 41-residue peptide hormone, on an experimental model of cold injury were examined. Male albino rats were anesthetized with sodium pentobarbital 60 mg/kg ip and the paws immersed for 1 or 2 min in a 22% NaCl solution maintained at -20 +/- 0.5 degrees C. Swelling in response to cold was measured by changes in paw volume using the fluid displacement method, and protein leakages from blood vessels were measured using Evans blue and Monastral blue dyes. Thirty minutes after cold exposure the paw volume increased from 1.5 +/- 0.1 to 2.4 +/- 0.1 ml/paw and the Evans blue content increased from 4 +/- 1 to 178 +/- 9 micrograms/pawskin. These responses to cold were inhibited by 40 to 60% after CRF was injected 56 micrograms/kg sc 30 min before or 28 micrograms/kg iv 10 min before or 5 min after cold exposures. Microscopic studies of the skin showed that CRF reduced leakage of Monastral blue pigment from the vascular compartment into the walls of capillaries and venules. The anti-inflammatory effects of CRF were blocked by alpha-helical CRF(9-41), a CRF receptor antagonist, injected 92 micrograms/kg iv 5 min before and 15 min before cold exposure.
Serda
S M
SM
School of Public Health, University of California, Berkeley 94720.
Wei
E T
ET
D000818:Animals; D002199:Capillary Permeability / Q000187:drug effects; D003080:Cold Temperature / Q000009:adverse effects*; D003346:Corticotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D004487:Edema / Q000517:prevention & control; D006487:Hemostasis / Q000187:drug effects; D007249:Inflammation / Q000517:prevention & control*; D008297:Male; D010446:Peptide Fragments / Q000494:pharmacology; D051381:Rats; D012867:Skin / Q000098:blood supply / Q000187:drug effects / Q000293:injuries*
D010446:Peptide Fragments; D003346:Corticotropin-Releasing Hormone; C045089:corticotropin releasing hormone (9-41)